25 Folate Duration of therapy Patients with pernicious anemia require lifelong therapy, while patients with malabsorption require treatment until underlying condition or diet is corrected
Suppressing it too aggressively with anti-inflammatory medications can actually impair healing
Patients are encouraged to discuss all potential treatments with their healthcare provider to ensure safety and efficacy
This guide works through the existing evidence systematically: the molecular biology that makes BPC-157 plausible, the dosing ranges tested in animal models, the limited but growing human data, and the practical considerations around administration route, cycling, and safety
This syndrome has been reported to be more likely if the patient has abnormal kidney function.9 Although there is some significant debate on this point10, it is generally agreed that patients with abnormal kidney function should start allopurinol at low doses and build up, to ensure that the allopurinol is effectively excreted
